Vision
Message from Haruhiko Inufusa
Dr. Haruhiko Inufusa

Haruhiko Inufusa
- Representative Director at TIMA Japan Corporation
- Physician
- Doctor of Medicine
- Specially appointed professor at the antioxidant division of Life Science Research Center, Gifu University
- Former professor at Kinki University
Background
1982 | Graduated from Faculty of Medicine, Kinki University |
1988 | Graduated from Graduate School of Medical Sciences, Kinki University, majored in surgical medicin |
1988~1990 | Postdoctoral Fellow at the Dr. Senichiro Hakomori class, Division of Biochemistry, university of Washington Seattle, U. S. A. |
Experience
1991~2000 | Faculty of Medicine, Lecturer at Kinki University |
2001~2003 | Professor at Department of Clinical Laboratory Medicine/Clinical Nutrition, Faculty of Medicine, Kinki University |
Apr.2004 ~ Oct. 2004 |
Visiting Professor at European Tele-Surgery Research Institute, Strasbourg University |
Nov. 2004 ~ Mar. 2005 |
Visiting Professor at the Division of Surgery, The University of Barcelona, Spain |
Apr. 2005 ~ Dec. 2006 |
Head of Office at Advanced Medicine/Health Economics Management Office, Faculty of Medicine, Kinki University |
2007~ Oct. 2013 |
Representative Director at Brookfield Medical Corporation |
2011 ~ Oct. 2013 |
Representative Director at TIMA Japan Corporation |
Company Information
Established | June 1, 2015 (※2006年12月1日創業) |
Representative | Representative Director and Chairman President Sho Tanaka |
Address |
・Tokyo Head Office ・Osaka branch社 |
Capital | JPY 21 million |
Major shareholders | European Medical Foundation TIMA |
Business description | SUPALIV Manufacturing and sales |
Established | June 21, 2019 |
Representative | Representative Director and Chairman President Sho Tanaka | Address |
・Tokyo Head Office ・Osaka branch社 |
Capital | JPY 8 million |
Major shareholders | European Medical Foundation TIMA |
Business description | Twendee X Manufacturing and sales |
Address | Alte Churer Strasse 45 FL-9496 Balzers Liechtenstein |
Director | Markus Count Matuschka de Greiffenclau |
Chief Researcher | Haruhiko Inufusa |
Board members, Special Counsel, and Ambassadors

Markus Count Matuschka de Greiffenclau
Chief Director at European Medical Foundation TIMA Foundation
Born in Germany. Since 1990, Providing investment and management consulting for companies such as
Skype.
In 2005, established TIMA Stiftung Foundation to donate to the medical research.
Currently, managing following companies also.
「Lysando(http://www.lysando.com/)」
CEOーThe biochemical patent owned company such as antibacterial agents without drug resistance cause,
etc. (Liechtenstein, Switzerland)
「Domaine Prive(www.cognac-cognac.com)」
Directorー Production and sales of wine and cognac (Cognac, France)

Haruhiko Inufusa
Sho Tanaka
Yohei Tsukamoto

Toshikazu Yoshikawa

Taku Nakashima

Helmut Durchschlag
Doctor at the Radiation physics study at University of Regensburg (Germany) http://www.researchgate.net/profile/Helmut_Durchschlag
Christian Amatore
Professor at the French Academy of Sciences(member of Institut de France)
Koji Fukui
History
January, 2001 | Establishment of TIMA Stiftung Foundation |
June, 2005 | Markus Matuschka v.Greiffenclau appointed as Chief Director at TIMA Stiftung. |
June, 2005 | Haruhiko Inufusa appointed as Chief Researcher at TIMA Stiftung. |
November, 2006 | Establishment of Brookfield Medical Corporation. |
November, 2010 | Start of selling “SUPALIV”. |
March, 2011 | Start of selling the new package”SUPALIV” designed by Mr. Kazunari Hitagawa. |
December, 2011 | Establishment of TIMA Japan Corporation for sales purpose. |
February, 2012 | Brookfield Medical Corporation merged and acquired TIMA Japan Corporation and named the company TIMA Japan Corporation. Start of selling “Oxicut”. |
November, 2013 | Developer Dr. Haruhiko Inufusa appointed to the Specially appointed professor of the Antioxidant Division, Life Science Research Center at Gifu University. |
July, 2015 | Establishment of SUPALIV Corporation for sales and marketing purposes. |